• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS
Device Problems Device Operates Differently Than Expected (2913); No Apparent Adverse Event (3189)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/03/2016
Event Type  malfunction  
Event Description
Leica biosystems received a complaint regarding sub-optimal processing of approximately 130 blocks in retort a.On (b)(6) 2016, leica biosystems received information that all tissue samples exhibiting sub-optimal processing were diagnosable.
 
Manufacturer Narrative
Investigation if this complaint by leica biosystems remains in progress.
 
Manufacturer Narrative
Investigation of this complaint found that the instrument operated within specification during execution of the "7hour" protocol, which started in retort a at 21:02 pm on (b)(4) 2016 and completed successfully at 07:45am on (b)(4) 2016, from which sub-optimal tissue processing was reported by the complainant.The root cause of the sub-optimal tissue processing reported was the combined use of ethanol from bottle 9 at a concentration of 80.2% for the fifth of the six dehydration steps in the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016; and ethanol from bottle 7 at a concentration of 70% for the final dehydration step in the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016.The minimum final reagent concentration required for ethanol is 98%.The consequences of using ethanol at a concentration less than the minimum required for the final dehydration step in a protocol is re-introduction of water into the tissue which cannot be displaced in subsequent processing steps; and contamination of reagents used in the subsequent processing steps, ultimately resulting in sub-optimal tissue processing.Although bottles 7 and 9 are designated as , bottles 7 and 9 were filled with 70% and 80% ethanol respectively on (b)(4) 2016 as detailed in mfr.Report# 8020030-2016-00041, which has been submitted previously.The root cause for bottles 9 and 7 being used for the penultimate and final dehydration steps of the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016 was a combination of the reagent management being set as .Reagents initially scheduled for use in the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016 had already been scheduled for a protocol which started in retort b prior to commencement of the protocol in retort a.As a consequence of the lack of availability of the reagent in bottles 5 and 4 initially scheduled for use in the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016, the instrument functioned as designed by allocating an alternative reagent with the lowest number of cycles for both the penultimate and final dehydration steps of the "7hour" protocol started in retort a at 21:02 pm on (b)(4) 2016, which was bottle 9 and 7 respectively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, victoria 3149
AS   3149
92117535
MDR Report Key5920043
MDR Text Key54410600
Report Number8020030-2016-00047
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 08/03/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received08/03/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/28/2006
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-